Gut check: study tests if tailored microbiome tips can shield C-Section babies from eczema
NCT ID NCT07333482
First seen Jan 12, 2026 · Last updated Jun 22, 2026 · Updated 28 times
Summary
This study enrolls 250 infants born by C-section to see if personalized diet and probiotic advice can improve their gut bacteria and reduce early signs of eczema. Babies provide stool samples over two years, and parents get tailored recommendations based on their baby's microbiome. The goal is to learn whether this kind of guidance can make a real difference for these infants' long-term health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROBIOTA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seeding Labs INC
RECRUITINGAustin, Texas, 78749, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
personalized dietary recommendations (educational guidance on probiotics, prebiotics, and nutrition)
What this could lead to
If successful, this could point toward a simple, scalable way to support gut health in C-section babies and potentially lower their risk of eczema and allergies.
What could go wrong
This is an early-stage study with no direct treatment given—only advice. It's small (250 infants) and observational in nature, so results may not be conclusive or widely applicable.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.